Medical Care

Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Research Report 2026

This report delivers a comprehensive overview of the global Isocitrate Dehydrogenase (IDH) Inhibitors market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Isocitrate Dehydrogenase (IDH) Inhibitors. The Isocitrate Dehydrogenase (IDH) Inhibitors market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Isocitrate Dehydrogenase (IDH) Inhibitors market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Isocitrate Dehydrogenase (IDH) Inhibitors manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Agios Pharmaceuticals
Bristol-Myers Squibb
Idenix Pharmaceuticals
Novartis
Bayer AG
Segment by Type
Oral Inhibitors
Intravenous Inhibitors
Segment by Application
Hospital
Research Center
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Isocitrate Dehydrogenase (IDH) Inhibitors companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Oral Inhibitors
1.2.3 Intravenous Inhibitors
1.3 Market by Application
1.3.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Research Center
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Perspective (2021–2032)
2.2 Global Isocitrate Dehydrogenase (IDH) Inhibitors Growth Trends by Region
2.2.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Isocitrate Dehydrogenase (IDH) Inhibitors Historic Market Size by Region (2021–2026)
2.2.3 Isocitrate Dehydrogenase (IDH) Inhibitors Forecasted Market Size by Region (2027–2032)
2.3 Isocitrate Dehydrogenase (IDH) Inhibitors Market Dynamics
2.3.1 Isocitrate Dehydrogenase (IDH) Inhibitors Industry Trends
2.3.2 Isocitrate Dehydrogenase (IDH) Inhibitors Market Drivers
2.3.3 Isocitrate Dehydrogenase (IDH) Inhibitors Market Challenges
2.3.4 Isocitrate Dehydrogenase (IDH) Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Isocitrate Dehydrogenase (IDH) Inhibitors Players by Revenue
3.1.1 Global Top Isocitrate Dehydrogenase (IDH) Inhibitors Players by Revenue (2021–2026)
3.1.2 Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue Market Share by Players (2021–2026)
3.2 Global Top Isocitrate Dehydrogenase (IDH) Inhibitors Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Isocitrate Dehydrogenase (IDH) Inhibitors Revenue
3.4 Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Concentration Ratio
3.4.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Isocitrate Dehydrogenase (IDH) Inhibitors Revenue in 2025
3.5 Global Key Players of Isocitrate Dehydrogenase (IDH) Inhibitors Head Offices and Areas Served
3.6 Global Key Players of Isocitrate Dehydrogenase (IDH) Inhibitors, Products and Applications
3.7 Global Key Players of Isocitrate Dehydrogenase (IDH) Inhibitors, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Isocitrate Dehydrogenase (IDH) Inhibitors Breakdown Data by Type
4.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Historic Market Size by Type (2021–2026)
4.2 Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecasted Market Size by Type (2027–2032)
5 Isocitrate Dehydrogenase (IDH) Inhibitors Breakdown Data by Application
5.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Historic Market Size by Application (2021–2026)
5.2 Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size (2021–2032)
6.2 North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2021–2026)
6.4 North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size (2021–2032)
7.2 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2021–2026)
7.4 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Size (2021–2032)
8.2 Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (2021–2026)
8.4 Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size (2021–2032)
9.2 Latin America Isocitrate Dehydrogenase (IDH) Inhibitors Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2021–2026)
9.4 Latin America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size (2021–2032)
10.2 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2021–2026)
10.4 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agios Pharmaceuticals
11.1.1 Agios Pharmaceuticals Company Details
11.1.2 Agios Pharmaceuticals Business Overview
11.1.3 Agios Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Introduction
11.1.4 Agios Pharmaceuticals Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)
11.1.5 Agios Pharmaceuticals Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Isocitrate Dehydrogenase (IDH) Inhibitors Introduction
11.2.4 Bristol-Myers Squibb Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Idenix Pharmaceuticals
11.3.1 Idenix Pharmaceuticals Company Details
11.3.2 Idenix Pharmaceuticals Business Overview
11.3.3 Idenix Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Introduction
11.3.4 Idenix Pharmaceuticals Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)
11.3.5 Idenix Pharmaceuticals Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Isocitrate Dehydrogenase (IDH) Inhibitors Introduction
11.4.4 Novartis Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)
11.4.5 Novartis Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Isocitrate Dehydrogenase (IDH) Inhibitors Introduction
11.5.4 Bayer AG Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)
11.5.5 Bayer AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Oral Inhibitors
Table 3. Key Players of Intravenous Inhibitors
Table 4. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (US$ Million), 2021–2026
Table 7. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Region (2021–2026)
Table 8. Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Region (2027–2032)
Table 10. Isocitrate Dehydrogenase (IDH) Inhibitors Market Trends
Table 11. Isocitrate Dehydrogenase (IDH) Inhibitors Market Drivers
Table 12. Isocitrate Dehydrogenase (IDH) Inhibitors Market Challenges
Table 13. Isocitrate Dehydrogenase (IDH) Inhibitors Market Restraints
Table 14. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue by Players (US$ Million), 2021–2026
Table 15. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Players (2021–2026)
Table 16. Global Top Isocitrate Dehydrogenase (IDH) Inhibitors Players by Tier (Tier 1, Tier 2, and Tier 3), based on Isocitrate Dehydrogenase (IDH) Inhibitors Revenue, 2025
Table 17. Ranking of Global Top Isocitrate Dehydrogenase (IDH) Inhibitors Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Isocitrate Dehydrogenase (IDH) Inhibitors Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Isocitrate Dehydrogenase (IDH) Inhibitors, Headquarters and Area Served
Table 20. Global Key Players of Isocitrate Dehydrogenase (IDH) Inhibitors, Products and Applications
Table 21. Global Key Players of Isocitrate Dehydrogenase (IDH) Inhibitors, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (US$ Million), 2021–2026
Table 24. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue Market Share by Type (2021–2026)
Table 25. Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue Market Share by Type (2027–2032)
Table 27. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (US$ Million), 2021–2026
Table 28. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue Market Share by Application (2021–2026)
Table 29. Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue Market Share by Application (2027–2032)
Table 31. North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (US$ Million), 2021–2026
Table 33. North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (US$ Million), 2027–2032
Table 46. Agios Pharmaceuticals Company Details
Table 47. Agios Pharmaceuticals Business Overview
Table 48. Agios Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Product
Table 49. Agios Pharmaceuticals Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (US$ Million), 2021–2026
Table 50. Agios Pharmaceuticals Recent Development
Table 51. Bristol-Myers Squibb Company Details
Table 52. Bristol-Myers Squibb Business Overview
Table 53. Bristol-Myers Squibb Isocitrate Dehydrogenase (IDH) Inhibitors Product
Table 54. Bristol-Myers Squibb Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (US$ Million), 2021–2026
Table 55. Bristol-Myers Squibb Recent Development
Table 56. Idenix Pharmaceuticals Company Details
Table 57. Idenix Pharmaceuticals Business Overview
Table 58. Idenix Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Product
Table 59. Idenix Pharmaceuticals Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (US$ Million), 2021–2026
Table 60. Idenix Pharmaceuticals Recent Development
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Isocitrate Dehydrogenase (IDH) Inhibitors Product
Table 64. Novartis Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (US$ Million), 2021–2026
Table 65. Novartis Recent Development
Table 66. Bayer AG Company Details
Table 67. Bayer AG Business Overview
Table 68. Bayer AG Isocitrate Dehydrogenase (IDH) Inhibitors Product
Table 69. Bayer AG Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (US$ Million), 2021–2026
Table 70. Bayer AG Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
Table 74. Authors List of This Report


List of Figures
Figure 1. Isocitrate Dehydrogenase (IDH) Inhibitors Picture
Figure 2. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Type: 2025 vs 2032
Figure 4. Oral Inhibitors Features
Figure 5. Intravenous Inhibitors Features
Figure 6. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Application: 2025 vs 2032
Figure 8. Hospital Case Studies
Figure 9. Research Center Case Studies
Figure 10. Other Case Studies
Figure 11. Isocitrate Dehydrogenase (IDH) Inhibitors Report Years Considered
Figure 12. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Region: 2025 vs 2032
Figure 15. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Players in 2025
Figure 16. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Isocitrate Dehydrogenase (IDH) Inhibitors Revenue in 2025
Figure 18. North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Country (2021–2032)
Figure 20. United States Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Country (2021–2032)
Figure 24. Germany Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Region (2021–2032)
Figure 32. China Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Country (2021–2032)
Figure 40. Mexico Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Country (2021–2032)
Figure 44. Israel Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Agios Pharmaceuticals Revenue Growth Rate in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)
Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)
Figure 49. Idenix Pharmaceuticals Revenue Growth Rate in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)
Figure 50. Novartis Revenue Growth Rate in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)
Figure 51. Bayer AG Revenue Growth Rate in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies